PCA3- ECONOMIC CONSEQUENCES OF MONOCLONAL ANTIBODY 17-1A ADJUVANT THERAPY OF RESECTED DUKES C COLORECTAL CARCINOMA IN GERMANY

Jan 1, 1999, 00:00 AM
10.1016/S1098-3015(11)70091-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)70091-2/fulltext
Section Title :
Section Order : 30
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70091-2&doi=10.1016/S1098-3015(11)70091-2
HEOR Topics :
Tags :
Regions :